US Patent Issued to Biocon on July 8 for "Fusion immunomodulatory proteins and methods for making same" (Indian Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,636, issued on July 8, was assigned to Biocon Ltd. (Bangalore, India).

"Fusion immunomodulatory proteins and methods for making same" was invented by Nagaraj Govindappa (Karnataka, India), Maria Melina Soares (Karnataka, India) and Kedarnath Sastry (Karnataka, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGFBetaRII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of...